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REVIEW
Abstract: Sensitization to the house dust mite (Dermataphagoides pteronyssinus) (HDM) is
the most common risk factor associated with the development of asthma in adults and children.
The effectiveness of HDM control measures in the treatment of asthma is not yet proven. The
strategies for control for avoidance depend on our understanding of the biology of the HDM.
The evidence suggests a favorable effect of transferring allergic asthmatic children to naturally
low dust mite environments, such as at altitude or in hospital, but little to suggest that this can
be replicated in general practice by simple practical measures such as mattress covers. However,
a recent multi-allergen reduction approach has suggested benefits may be achievable. HDM
densities tend to be high in warm, humid conditions in the home, which may be modified by
external factors, such as ventilation. However, ventilation control to reduce indoor humidity
has had inconsistent effects on dust mite levels and asthma. The challenge is to further refine
the interventions in large placebo-controlled trials such that clinical outcomes may be more
easily demonstrated.
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Introduction
Asthma is a common chronic disease, affecting 300 million people worldwide. It is
diagnosed on the basis of symptoms of wheeze, dyspnoea and cough and by evidence
of variable airflow obstruction. There has been an increase in prevalence over the
last 30 years, despite progress in understanding of pathogenesis and improved
treatment. The reason for the increase is unknown, but is unlikely that genetic
susceptibility has changed within a single generation, but is being unmasked as a
result of environmental changes (Frew 2003). It is important to identify these
environmental triggers as they may be amenable to change, and may reverse the
rapid increase in asthma. Environmental manipulation may even have a therapeutic
effect on established disease. The house dust mite (HDM) is an environmental agent
commonly associated with asthma. The aim of this review is to discuss the evidence
for the efficacy of HDM avoidance in the treatment of asthma.
Atopy and asthma
Rackeman classified asthma as intrinsic or extrinsic (Rackeman 1947). He noted
that extrinsic asthma started before the age of 30 years. Now called allergic asthma,
it is associated with atopy, the genetic predisposition for the development of an
immunoglobulin E (IgE)-mediated response to common aeroallergens. IgE is the
class of immunoglobulin that has protective antibody activity, usually against parasitic
antigens. It may cause inappropriate inflammatory reactions when the antibody activity
is directed against innocuous environmental proteins such as pollen, causing hay
fever. Intrinsic or non-allergic asthma starts in middle age and is not associated with
atopy.
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Atopic sensitization to the HDM (Dermataphagoides
pteronyssinus) is commonly associated with asthma.
Dermatophagoides pteronyssinus (Figure 1) is a
pyroglyphid mite, described as the source of common house
dust allergen in 1964 (Voorhorst et al 1964). The life cycle
of the HDM is critically affected by ambient relative
humidity and temperature (Wharton and Richards 1978).
The importance of the HDM in a West of Scotland
general allergy clinic population is shown in Figure 2. Three
quarters of the atopic subjects are sensitive to HDM, half to
grass pollen, one quarter to cat dander and about 10% to
dog dander. From these proportions, most of the individuals
are sensitive to a combination of allergens but HDM is the
most frequent sensitizer.
The association between HDM
exposure and asthma
Bradford-Hill (1965) proposed criteria for demonstrating
causality between an environmental agent and a non-
infectious disease. The frequent association of HDM and
asthma is, in his words, “clear-cut and beyond what we
would care to attribute to the play of chance”. However, it
does not prove causation. The association must be assessed
by his criteria: strength and consistency, dose-response
relationship, and of introduction or withdrawal of
allergen.
Strength of association
House dust mite sensitization is a risk factor for the
development of asthma in adults and children (Nelson 2000).
The strength of association has been documented in
numerous studies in diverse environments across the world.
(Sporik et al 1990; Wong et al 2002; Emin et al 2004). For
example, Sears and colleagues (1989) conducted a
longitudinal study of a New Zealand birth cohort to 13 years
and showed that allergies to HDM and cat were highly
significant independent risk factors associated with the
development of asthma.
Figure 1 A light micrograph of a house dust mite (Dermatophagoides pteronyssinus). These mites are around 100–300 µm and their secretions contain multiple soluble
allergenic proteins. Glasgow University Hunterian Museum Zoology Specimen 127238.Therapeutics and Clinical Risk Management 2006:2(4) 349
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Dose-response relationship
Sporik and colleagues (1990) showed that all but one of 67
children with asthma at age 11 had been exposed to the
allergen Der p1 at greater than 10 µg/g dust at the age of 1
year. The relative risk of asthma was 4.8 with the age of
onset of wheeze being inversely related to the level of early
exposure. In 1996, Peat and colleagues (1996) evaluated
the gradation of relative air humidity and corresponding
levels of domestic HDM levels in homes across 6 regions
of New South Wales. As mite numbers increased there was
an increased prevalence of HDM sensitization which was
associated with an increased prevalence of airway
hyperresponsiveness and wheeze. In 2001, the Childhood
Asthma Management Program found that for HDMs, the
higher the level of allergen exposure, the more likely patients
were to have positive allergy skin test responses, with
relative odds of 9.0 (95% confidence interval, 5.4–15.1)
for those exposed to high mite levels (>10.0 µg/g dust)
relative to those unexposed. Even exposure to low levels of
mite allergen (0.020–2.0 µg/g) was found to be a significant
risk factor for sensitization (Huss et al 2001).
Custovic and colleagues (1996) found clinical activity
and severity of asthma, (measured by the level of bronchial
hyperreactivity [BHR], peak expiratory flow rate [PEFR]
variability, and percent predicted forced expiratory volume
in one second [FEV1]) in mite-sensitive patients, related to
exposure to mite allergens in the dust reservoir.
Not all studies however find such a convincing
association. Carter and colleagues (2003) found that
although HDM sensitization and asthma were concurrently
related, there was no relationship between level of HDM
allergen exposure in children’s bedrooms in early childhood
and development of bronchial hyperresponsiveness or
physician-diagnosed asthma by age 6 to 7 years.
Allergen challenge
Soluble extracts of house dust, HDMs or individual purified
allergens from HDMs can induce an asthmatic reaction in
subjects with asthma. This can be monitored as wheeze and
bronchoconstriction shortly after inhaling allergen (Van der
Veen et al 2001; Lophua et al 2003). This occurs in asthma
patients who are already sensitive to HDM allergens, and
this provides convincing evidence that exposure can cause
symptoms, but does not answer the question whether
exposure can induce sensitivity in a non-sensitized
individual.
World Health Organization
recommendations
The importance of the role of the HDM in allergic disease
prompted the World Health Organization (WHO) to design
guidelines for its control. It suggested that exposure to 2 µg
Der p1 per g of dust increased the risk of sensitization.
Exposure to 10 µg Der p1 per g of dust increases the risk of
symptoms. Absolute humidity of 7 g/kg has been stipulated
as the limiting factor for the growth of colonies (Platts-Mills
and de Weck 1989).
Scotland has the highest incidence of adolescent asthma
in the world. We quantified the allergen content in carpets
in 139 randomly selected Scottish homes. The dot plot in
Figure 3 highlights the distribution of HDM allergen
concentration. About two thirds of the carpets had levels
above the WHO recommended sensitization limit of 2 µg/g
(Figure 3; lower line), and about half had levels greater than
the recommended clinical safety limit of 10 µg/g (Figure 3;
higher line).
Reduction of HDM exposure
The association between HDM exposure and asthma appears
to justify it as a target for control measures. However, other
agents may influence lung function (Platts-Mills 2003). Cat,
cockroach and other allergens, levels of endotoxin exposure
and rhinovirus infection may all promote symptoms in a
predisposed individual. Nevertheless, it may not be
Figure 2 The proportion of atopic individuals from a West of Scotland general
allergy clinic with serum IgE antibody to the allergens from house dust mite,
grass, cat, and dog dander.
Abbreviations: IgE, immunoglobin E.Therapeutics and Clinical Risk Management 2006:2(4) 350
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necessary to prove that the HDM is the exclusive cause of
asthma to demonstrate that eradication may improve
symptoms. A number of observations of naturally low
allergen environments have supported avoidance as an
effective intervention.
Altitude
A number of studies have demonstrated the favorable effect
of transferring allergic asthmatic children to high altitude
Alpine sanatoria, where the natural levels of HDMs are
low. Reduction in bronchial hyperresponsiveness and
airway inflammation have been shown following
residence at altitude (Peroni et al 1994, 2002; Piacentini
et al 1999).
The Tokelau hurricanes
After hurricane damage to the Tokelau atolls in 1966, half
of the population resettled in New Zealand. Children in
Tokelau have a lower prevalence of asthma and atopy
compared with those Tokelaun children resident in New
Zealand. Lane and colleagues (2005) measured very low
indoor allergen levels in Tokelau to provide an explanation
for the lower prevalence of asthma and atopy, compared
with New Zealand.
Hospital environment
The concept of treating patients in a mite-reduced
environment has been extended to admitting asthmatic
children to hospital (Platts-Mills et al 1982). The dust mite
allergen levels in hospital were on average <2% of that found
at home. In this environment, clinical remission and
reduction of bronchial hyper-responsiveness were noted.
Application of mite control
measures
The current challenge is to replicate such low allergen
environments in family homes.
House dust mite avoidance appeals as a simple, non-
pharmacological maneuver, but the effectiveness of
domestic eradication measures is not yet proven. Possible
strategies for control will depend on our understanding of
mite biology. The life cycle of the HDM is influenced by
ambient relative humidity and temperature. Mites actively
extract water from unsaturated air by an elegant hygroscopic
pump, but water is lost due to mite activities such as feeding
and defecation. The critical equilibrium is the relative
humidity below which water loss is greater than water intake.
Mites feed on human skin scales and are therefore abundant
in bedding, carpets, soft furniture, and toys. The scales must
be moist to permit digestion. Feeding rates and therefore,
nutritional uptake and reproduction, are affected if the
moisture content of the food is not high enough.
As relative humidity rises above the critical equilibrium
humidity, feeding, mating, and egg production all increase
(Arlian 1992), and as it falls, mite activity is reduced until
death occurs secondary to dehydration. However, mites may
be able to survive periods of dehydration if there are brief
spells of elevated humidity (de Boer et al 1998).
Intervention strategies to control
domestic HDM numbers.
The first example of medically instituted allergen avoidance
for asthma was by Jerome Cardan in 1552. For the princely
sum of 1400 gold pieces, Cardan successfully treated John
Hamilton, the Archbishop of St Andrews, by advising
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Figure 3 Dot plot illustrating the individual concentrations of the major house dust mite allergen Der p1 measured as µg per g of settled house dust collected from
carpets in 139 randomly selected houses in the West of Scotland.
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removal of his feather bedding (Avenberg 1980). More
recently, there have been a large number of studies
examining physical and chemical methods of eradication
(Table 1). The basis of these methods was varied. These
ranged from using impermeable mattress covers to provide
a physical barrier, chemical acaricides or liquid nitrogen,
high efficiency vacuuming or improving home ventilation
and humidity. Successful eradication involves both removal
of residual mites and prevention of recolonization. Evidence
conflicts as to whether vacuuming reduces dust mite
concentration, but it is generally accepted that intensive
vacuuming significantly reduces the mass of allergen in
carpets (Causer et al 2004). Washing bedding at least weekly
in warm water with detergent removes virtually all mite
allergen. Several clinical trials of allergen-proof covers fitted
to mattress and pillows have been published and the mite
allergen levels in bedding could be reduced by a median of
89% (range 39%–99.9%) (Eggleston 2005).
However, an objective meta-analysis of these
interventions suggested that in general the evidence for their
success was equivocal (Gotzche et al 1998). To make sense
of seemingly inconclusive data, two measures of
effectiveness must be distinguished: reduction in allergen
exposure (efficacy) and impact on symptomatic illness
(clinical effectiveness) (Strachan 1999).
The first Cochrane review of HDM control measures in
1998 concluded that current methods were “ineffective” and
“could not be recommended” (Gotzche et al 1998). It
reviewed randomized controlled trials that compared
chemical or physical measures with no treatment, in patients
with asthma diagnosed by a physician, and with confirmed
sensitization to the HDM. Only five trials showed a
reduction in mite allergen level in the intervention group.
Only four of these reported changes in morning peak flow
rate, the primary end-point. Strachan (1999) commented on
these, stating that this was a conservative approach to meta-
analysis, as other outcomes, such as symptomatic
improvement or bronchial hyper-responsiveness, were not
considered.
This was an unexpected result: firstly, as de Vet (1999)
argued, it was contrary to conventional reasoning, such that
reduced allergen exposure should reduce symptoms in a
sensitized individual. Second, she observed that the results
conflicted with a narrative review by Custovic and
colleagues (1998). Of the 31 studies considered, Custovic
and colleagues (1998) had eliminated those which used air
ionisers or cleaners. Of the remaining 24, they excluded
those which were not randomized or controlled, did not
measure allergen levels, or were not measured for sufficient
time. They considered 6 controlled studies to have used an
efficacious intervention. There was some evidence of clinical
benefit in each, such as improved lung function, symptoms,
or medication use.
Thereafter, there was a call for larger and more rigorous
randomized trials, particularly to evaluate methods other
than those used to date. Woodcock and colleagues (2003)
responded with a large randomized placebo-controlled
double-blind trial to establish the effect of allergen-
impermeable mattress covers on adult asthma in general
practice. The key finding was that there was no significant
reduction in mite allergen level at 12 months. There was no
parallel change in asthma control (Figure 4). This study
concluded that mattress covers, as a single intervention,
seem clinically ineffective in a population of adults with
asthma. The Cochrane Review included this trial in its update
in 2004, which evaluated 49 trials, 31 physical methods, 10
chemical methods, and 8 using a combination of both
(Gotzche et al 2004). They concluded that these methods
could not be recommended for asthma. The most plausible
explanation they suggested that the methods reviewed did
not adequately reduce the mite allergen levels.
Morgan and colleagues (2004) designed and
implemented an individualized, comprehensive
environmental intervention to decrease exposure to multiple
allergens including HDM in inner city children with atopic
asthma. They demonstrated a significant reduction in
asthma, and asthma-associated morbidity. This was a highly
powered study using 937 patients in 7 inner city locations,
and provided proof-of-concept evidence that environmental
control of HDM could improve asthma. It would be
interesting to address in future studies the issues of whether
those of different severities are affected differently and the
Table 1 A list of physical and chemical interventions used to
reduce and remove house dust mites and their allergens from
the indoor environment
INTERVENTION
Physical methods
Barrier methods eg, impermeable mattress and pillow covers
Detergent and hot wash bedding
Steam cleaning carpets Ventilation
Dehumidifiers
Ionisers
Chemical methods
Acaricide sprays eg, benzyl benzoate
Liquid nitrogen
Tannic acidTherapeutics and Clinical Risk Management 2006:2(4) 352
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complexity of the different environments of home, work,
and leisure affecting any one individual.
Using ventilation to control HDM
Mite densities tend to be high in warm, humid climates.
However conditions in the home may be affected by other
factors such as ventilation and season. Achieving the
required hygrothermal conditions to control mite
populations in temperate climates may be more complex
than in cool, dry climates
Ventilation control to reduce indoor humidity
(dehumidifiers) has had inconsistent results. In one study,
portable dehumidifiers were unable to reduce either
humidity or mite allergen levels (Custovic et al 1994). In
another study, mite allergen levels were unaffected by heat
exchangers despite maintaining indoor relative humidity at
less than 40% (Niven et al 1999). However, Arlian and
colleagues (2001) was able to maintain relative humidity at
less than 51% throughout a 2-year period in approximately
half of the homes tested, and mites and mite allergen in the
carpets from these homes decreased by 78%.
Mechanical heat recovery ventilation (MHRV) is a
method of active ventilation using both an extraction and a
supply fan. The airflows are separate, but pass across a heat
exchanger allowing conservation of heat energy. This was
first used successfully by a Danish group led by Harving
(Harving et al 1994a). Their paper suggested that HDM
exposure was reduced in specially designed, mechanically
ventilated ‘healthy homes’. Exposure to HDMs was
investigated in 30 asthmatic patients before and after moving
to homes with mechanical ventilation systems. Air exchange
rates increased with an associated reduction in indoor
absolute humidity. There was a reduction from 110 mites/g
dust to 20 mites/g dust over a 5 month period. The authors
concluded that the reduction of air humidity through an
increased supply of fresh air might significantly diminish
and may in some cases eliminate mites in homes.
A second paper from this group (Harving et al 1994b)
examined clinical efficacy in such homes, evaluating the
effect on asthma control for 14 patients. After 5 months, the
active subjects had improved lung function measured by
FEV1, average peak expiratory flow, medicine-use score,
symptom score, and serum IgE level. There were non-
significant trends in response to histamine provocation and
blood eosinophil count. A significant relation was found
between reduction in medicine score and fall in HDM
exposure. They concluded that, not only was MHRV
effective in reducing allergen exposure, but that it had a
clinically demonstrable effect on improving asthma
symptoms. However, the methodology of this trial, although
complex and innovative, could be criticized because there
was no randomization, no blinding, and no placebo control
of home-move to a non-MHRV house.
Singh and colleagues (2002) undertook a systematic
review of clinical trials for humidity control for chronic
asthma. This review was a search of the clinical trial registers
of the Cochrane collaboration and the Cochrane Airways
Group using search terms for asthma and humidity or water
vapor. All randomized controlled trials on the use of
humidity control measures in the home environment of
patients with asthma were evaluated. The authors concluded
that only one trial could be included. This was by Warner
and colleagues (2000) who studied 40 patients in a parallel-
randomized controlled trial over 12 months. She compared
Figure 4 Mean morning peak expiratory flow rate in the Active-Intervention
and Control Groups at Base Line, 6 Months, and 12 Months among All Patients
(Panel A) and among Mite-Sensitive Patients (Panel B). Data points represent the
geometric means, and I bars the 95 percent confidence intervals. Copyright ©
2003. Reproduced with permission from Woodcock A, Forster, L, Matthews, et al.
2003. Control of exposure to mite allergen and allergen-impermeable bed
covers for adults with asthma. N Eng J Med, 349:225-36.Therapeutics and Clinical Risk Management 2006:2(4) 353
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MHRV with high efficiency vacuum cleaning, MHRV alone,
high efficiency vacuum cleaning alone, and no intervention
in 4 groups of 10 patients. There was no blinding, as no
placebo humidifier was used. The trial authors reported no
significant differences in any of the subjective patient
outcomes; however they indicated a trend towards an
improvement in the response to histamine challenge.
Allergen levels and HDM counts decreased in bedroom
carpets, but not in mattresses and sofas. They concluded
that there is requirement for a double blind randomized
controlled trial with adequate sample size measuring clinical
outcomes in patients with asthma.
Conclusions and future directions
The role of the indoor environment in asthma is of major
concern as we spend much of our lives indoors. Asthma has
become more prevalent and severe, and the majority of
allergic asthmatic children are sensitive to indoor allergens.
There have been many attempts to reduce the impact of
asthma by reducing indoor allergens, primarily HDM. These
are difficult and costly studies and in general their efficacy
has been unconvincing. Various meta-analysis and review
studies have signaled that simple interventions do little to
reduce HDM allergen levels. The Cochrane Review of 2004
(Gotzche et al 2004) concluded that individual chemical
and physical methods cannot be recommended and suggest
that studies need to use other innovative, more rigorous
methodology, with clinical outcomes, and improved
methods for quantifying dust mite exposure. In addition,
these reviews suggest that the length of time needed for an
intervention to follow through should be at least 12 months.
Environmental controls are not easy, but Morgan and
colleagues (2004) shows that although it is possible, further
fully powered studies are required. The challenge is to
further refine the interventions so that clinical outcomes may
be more easily demonstrated.
This challenge is now 2-fold. Firstly to design an
intervention strategy that uses the best evidence-base from
the most promising published methods, and secondly to use
this to impact on building regulations to encourage change
in the design, construction and use patterns of domestic
buildings in the UK. Since the changes to the Building
Regulations in response to the energy crisis of 1974, there
has been increasing resistivity of the building fabric and
‘tighter’ construction techniques for example, double-
glazing, central heating and changing lifestyles. These have
resulted in a warmer and more humid domestic environment
that is the perfect microclimate for the proliferation of
HDMs. A major international objective should be to
understand and reverse this as a practical intervention in
asthma.
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